The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients.

Utako Ishimoto,Akiyoshi Kinoshita,Yuki Hirose,Keiko Shibata,Ayako Ishii,Ryo Shoji,Takeharu Yokota,Akira Iwaku,Yusuke Mizuno,Kazuhiko Koike,Masayuki Saruta

The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients.

2019

Utako Ishimoto
Akiyoshi Kinoshita
Yuki Hirose
Keiko Shibata
Ayako Ishii
Ryo Shoji
Takeharu Yokota
Akira Iwaku
Yusuke Mizuno
Kazuhiko Koike
Masayuki Saruta

Purpose To evaluate the efficacy and safety of nab paclitaxel (nab-P) plus gemcitabine (GEM) in elderly patients ≥ 75 years old with unresectable pancreatic cancer (PC) compared with younger patients.

Keywords:

Gemcitabine
Nab-paclitaxel
Pharmacology
Unresectable Pancreatic Cancer
Internal medicine
Oncology
Medicine
Multivariate analysis
Pancreatic cancer
Chemotherapy
Adverse effect
Neutropenia
Gastroenterology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations